Topic Information
Target Audience:
Nurse practitioners and physician assistants involved in the management of patients with GI disorders and chronic liver disease.
Educational Objectives:
At the conclusion of this activity, participants will be able to:
- Compare the strength of data supporting the role of microbiota in various diseases
- Describe AGA's recommendations for probiotic use in various populations/underlying disease states
Release Date: 01/15/21
Expiration Date: 01/15/22
*This program has expired. CME credit is no longer available.
Accreditation Statement
ANCC Accreditation
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. A maximum of 0.5 contact hours may be earned for successful completion of this activity.
Nurse Practitioner Statement
This program has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Gastroenterology and Hepatology Advanced Practice Providers. The Annenberg Center for Health Sciences at Eisenhower is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207
This program is accredited for 0.5 contact hour(s). Program ID #5838
Physician Assistant Statement
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 7.5 AAPA Category 1 CME credits. Approval is valid from 1/15/2021 to 1/15/2022. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-201856.
Please note, each session is eligible for 0.5 credits.
Disclosure of Conflicts of Interest
All individuals in control of the content of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. All other staff at the Annenberg Center for Health Sciences at Eisenhower and GHAPP have no relationships to disclose.
Learner Assurance Statement
The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of individuals who control activity content and who have relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those individuals with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
Faculty Disclosures
Dr. Susan T. Wolgamott
Speakers Bureau: AbbVie, Clinical Area - IBD, EPI, (previously Allergan) - IBS-D, IBS-C, CIC
Speakers Bureau: Salix, Clinical Area - IBS-D IBS-C, CIC, HE
Speakers Bureau: Ironwood, Clinical Area- IBS-D
Sub-Investigator: Clinical Research Institute of Michigan, Clinical Area - IBD, IBS-D, IBS-C, CIC, Chronic Pancreatitis, Gastroparesis, GERD, EoE, Colonoscopy Prep, NASH, Cirrhosis, HE, Celiac Disease, Smoking Cessation
This activity is supported by an educational grant from: AbbVie, Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc., Pfizer Inc., and Takeda Pharmaceuticals U.S.A, Inc.
Accredited by
